Qualigen Therapeutics Stock Target Price and Analyst Consensus
| QLGN Stock | USD 3.41 0.07 2.10% |
The current analyst and expert consensus on Qualigen Therapeutics is Strong Buy, with only one strong buy opinion. The current projected Qualigen Therapeutics target price consensus is 40.00 with 1 analyst opinions. Check out Macroaxis Advice on Qualigen Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Qualigen Stock, please use our How to Invest in Qualigen Therapeutics guide.The most common way Qualigen Therapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Qualigen Therapeutics executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Qualigen Therapeutics. We encourage you to use your own analysis of Qualigen Therapeutics to validate this buy or sell advice. Qualigen Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Qualigen Therapeutics target price to derive its highest and lowest estimates based on projected price volatility of 5.9097.
Lowest Forecast 36.4 | Highest Forecast 44.4 | Target Price 40 |
Qualigen |
It's important to approach Qualigen Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Qualigen Therapeutics Target Price Consensus
Qualigen target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Qualigen Therapeutics' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| One | Strong Buy |
Most Qualigen analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Qualigen stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Qualigen Therapeutics, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationQualigen Therapeutics Target Price Projection
Qualigen Therapeutics' current and average target prices are 3.41 and 40.00, respectively. The current price of Qualigen Therapeutics is the price at which Qualigen Therapeutics is currently trading. On the other hand, Qualigen Therapeutics' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Qualigen Therapeutics Market Quote on 30th of January 2025
Target Price
Analyst Consensus On Qualigen Therapeutics Target Price
Qualigen Therapeutics Analyst Ratings
Qualigen Therapeutics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Qualigen Therapeutics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Qualigen Therapeutics' financials, market performance, and future outlook by experienced professionals. Qualigen Therapeutics' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Qualigen Therapeutics price targets
Qualigen Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Qualigen Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Qualigen Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Qualigen Therapeutics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Qualigen Therapeutics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Qualigen Therapeutics is a key component of Qualigen Therapeutics valuation and have some predictive power on the future returns of a Qualigen Therapeutics.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Power Assets Invested over 300 shares | |
 | Driverless Cars Invested over 50 shares | |
 | Hedge Favorites Invested over 100 shares | |
 | Investor Favorites Invested few shares | |
 | Banking Invested over 30 shares | |
 | Momentum Invested over 60 shares | |
 | Business Services Invested few shares | |
 | Warren Buffett Holdings Invested few shares | |
 | Automobiles and Trucks Invested over 300 shares | |
 | Chemicals Invested over 30 shares | |
 | Artificial Intelligence Invested few shares |
Check out Macroaxis Advice on Qualigen Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Qualigen Stock, please use our How to Invest in Qualigen Therapeutics guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.